Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
34230 | 114 | 41.5 | 93% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
455 | 3 | HEMOGLOBIN//SICKLE CELL DISEASE//SICKLE CELL ANEMIA | 25359 |
1216 | 2 | PU1//ETS 1//GATA 1 | 9149 |
34230 | 1 | BCL11B//BCL11B GENE//BCL11A EXPRESSION | 114 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BCL11B | authKW | 4537784 | 21% | 71% | 24 |
2 | BCL11B GENE | authKW | 803568 | 3% | 100% | 3 |
3 | BCL11A EXPRESSION | authKW | 535712 | 2% | 100% | 2 |
4 | PROT INTERACT SIGNALING | address | 535712 | 2% | 100% | 2 |
5 | CTIP1 | authKW | 357140 | 2% | 67% | 2 |
6 | ATROPHIC THYMUSES | authKW | 267856 | 1% | 100% | 1 |
7 | BCL 11B | authKW | 267856 | 1% | 100% | 1 |
8 | BCL11A XL | authKW | 267856 | 1% | 100% | 1 |
9 | BCL11B MICE | authKW | 267856 | 1% | 100% | 1 |
10 | BCL11B TUMOR SUPPRESSOR | authKW | 267856 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 451 | 33% | 0% | 38 |
2 | Hematology | 356 | 18% | 0% | 20 |
3 | Genetics & Heredity | 162 | 17% | 0% | 19 |
4 | Biochemistry & Molecular Biology | 122 | 30% | 0% | 34 |
5 | Cell Biology | 88 | 16% | 0% | 18 |
6 | Immunology | 67 | 13% | 0% | 15 |
7 | Developmental Biology | 46 | 4% | 0% | 5 |
8 | Medicine, Research & Experimental | 38 | 8% | 0% | 9 |
9 | Biophysics | 22 | 6% | 0% | 7 |
10 | Dermatology | 9 | 3% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PROT INTERACT SIGNALING | 535712 | 2% | 100% | 2 |
2 | CNRSU 567UMR 8104 HEMATOL | 267856 | 1% | 100% | 1 |
3 | EA7292DYNAM HOST PATHOGEN INTERACT | 267856 | 1% | 100% | 1 |
4 | INSERM PASTEUR LILLEU1019UMR8204CIIL | 267856 | 1% | 100% | 1 |
5 | MED NEUROSURG NEUROLPROGRAM NEUROSCI | 267856 | 1% | 100% | 1 |
6 | NERVOUS SYST REPAIRNAYEF AL RODHAN S | 267856 | 1% | 100% | 1 |
7 | UMRE 01 | 267856 | 1% | 100% | 1 |
8 | SEATTLE CANC ALLIANCE | 214282 | 2% | 40% | 2 |
9 | BASIC NEUROSCI BRANCH | 133927 | 1% | 50% | 1 |
10 | IUT LOUIS PASTEUR | 133927 | 1% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF HEMATOLOGY & ONCOLOGY | 3571 | 3% | 0% | 3 |
2 | GENE EXPRESSION PATTERNS | 2417 | 3% | 0% | 3 |
3 | MOLECULAR CANCER | 1360 | 3% | 0% | 3 |
4 | HEMATOLOGY | 1095 | 2% | 0% | 2 |
5 | CANCER SCIENCE | 680 | 3% | 0% | 3 |
6 | CANCER GENETICS | 647 | 1% | 0% | 1 |
7 | NATURE IMMUNOLOGY | 483 | 2% | 0% | 2 |
8 | LEUKEMIA RESEARCH | 395 | 3% | 0% | 3 |
9 | CANCER GENETICS AND CYTOGENETICS | 391 | 3% | 0% | 3 |
10 | ONCOGENE | 365 | 4% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BCL11B | 4537784 | 21% | 71% | 24 | Search BCL11B | Search BCL11B |
2 | BCL11B GENE | 803568 | 3% | 100% | 3 | Search BCL11B+GENE | Search BCL11B+GENE |
3 | BCL11A EXPRESSION | 535712 | 2% | 100% | 2 | Search BCL11A+EXPRESSION | Search BCL11A+EXPRESSION |
4 | CTIP1 | 357140 | 2% | 67% | 2 | Search CTIP1 | Search CTIP1 |
5 | ATROPHIC THYMUSES | 267856 | 1% | 100% | 1 | Search ATROPHIC+THYMUSES | Search ATROPHIC+THYMUSES |
6 | BCL 11B | 267856 | 1% | 100% | 1 | Search BCL+11B | Search BCL+11B |
7 | BCL11A XL | 267856 | 1% | 100% | 1 | Search BCL11A+XL | Search BCL11A+XL |
8 | BCL11B MICE | 267856 | 1% | 100% | 1 | Search BCL11B+MICE | Search BCL11B+MICE |
9 | BCL11B TUMOR SUPPRESSOR | 267856 | 1% | 100% | 1 | Search BCL11B+TUMOR+SUPPRESSOR | Search BCL11B+TUMOR+SUPPRESSOR |
10 | C TERMINAL BINDING PROTEIN INTERACTING PROTEIN 2 CTIP2 | 267856 | 1% | 100% | 1 | Search C+TERMINAL+BINDING+PROTEIN+INTERACTING+PROTEIN+2+CTIP2 | Search C+TERMINAL+BINDING+PROTEIN+INTERACTING+PROTEIN+2+CTIP2 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KOMINAMI, R , (2012) ROLE OF THE TRANSCRIPTION FACTOR BCL11B IN DEVELOPMENT AND LYMPHOMAGENESIS.PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES. VOL. 88. ISSUE 3. P. 72 -87 | 34 | 37% | 11 |
2 | CHEN, S , HUANG, X , CHEN, SH , YANG, LJ , SHEN, Q , ZHENG, HT , LI, B , GRABARCZYK, P , PRZYBYLSKI, GK , SCHMIDT, CA , ET AL (2012) THE ROLE OF BCL11B IN REGULATING THE PROLIFERATION OF HUMAN NAIVE T CELLS.HUMAN IMMUNOLOGY. VOL. 73. ISSUE 5. P. 456-464 | 18 | 53% | 4 |
3 | KUROSAWA, N , FUJIMOTO, R , OZAWA, T , ITOYAMA, T , SADAMORI, N , ISOBE, M , (2013) REDUCED LEVEL OF THE BCL11B PROTEIN IS ASSOCIATED WITH ADULT T-CELL LEUKEMIA/LYMPHOMA.PLOS ONE. VOL. 8. ISSUE 1. P. - | 18 | 47% | 6 |
4 | GRABARCZYK, P , NAHSE, V , DELIN, M , PRZYBYLSKI, G , DEPKE, M , HILDEBRANDT, P , VOLKER, U , SCHMIDT, CA , (2010) INCREASED EXPRESSION OF BCL11B LEADS TO CHEMORESISTANCE ACCOMPANIED BY G1 ACCUMULATION.PLOS ONE. VOL. 5. ISSUE 9. P. - | 18 | 51% | 2 |
5 | LIAO, CK , FANG, KM , CHAI, K , WU, CH , HO, CH , YANG, CS , TZENG, SF , (2016) DEPLETION OF B CELL CLL/LYMPHOMA 11B GENE EXPRESSION REPRESSES GLIOMA CELL GROWTH.MOLECULAR NEUROBIOLOGY. VOL. 53. ISSUE 6. P. 3528 -3539 | 17 | 47% | 0 |
6 | LE DOUCE, V , CHERRIER, T , RICLET, R , ROHR, O , SCHWARTZ, C , (2014) CTIP2, A MULTIFUNCTIONAL PROTEIN: CELLULAR PHYSIOPATHOLOGY AND THERAPEUTIC IMPLICATIONS.M S-MEDECINE SCIENCES. VOL. 30. ISSUE 8-9. P. 797 -802 | 17 | 46% | 1 |
7 | SHEN, Q , HUANG, X , CHEN, S , YANG, LJ , CHEN, SH , LI, B , WU, XL , GRABARCZYK, P , PRZYBYLSKI, GK , SCHMIDT, CA , ET AL (2012) BCL11B SUPPRESSION DOES NOT INFLUENCE CD34(+) CELL DIFFERENTIATION AND PROLIFERATION.HEMATOLOGY. VOL. 17. ISSUE 6. P. 329-333 | 12 | 67% | 0 |
8 | GU, XG , WANG, Y , ZHANG, GL , LI, WW , TU, P , (2013) ABERRANT EXPRESSION OF BCL11B IN MYCOSIS FUNGOIDES AND ITS POTENTIAL ROLE IN INTERFERON-INDUCED APOPTOSIS.JOURNAL OF DERMATOLOGY. VOL. 40. ISSUE 8. P. 596-605 | 17 | 44% | 3 |
9 | KARANAM, NK , GRABARCZYK, P , HAMMER, E , SCHARF, C , VENZ, S , GESELL-SALAZAR, M , BARTHLEN, W , PRZYBYLSKI, GK , SCHMIDT, CA , VOLKER, U , (2010) PROTEOME ANALYSIS REVEALS NEW MECHANISMS OF BCL11B-LOSS DRIVEN APOPTOSIS.JOURNAL OF PROTEOME RESEARCH. VOL. 9. ISSUE 8. P. 3799 -3811 | 22 | 36% | 4 |
10 | OBATA, M , KOMINAMI, R , MISHIMA, Y , (2012) BCL11B TUMOR SUPPRESSOR INHIBITS HDM2 EXPRESSION IN A P53-DEPENDENT MANNER.CELLULAR SIGNALLING. VOL. 24. ISSUE 5. P. 1047-1052 | 15 | 47% | 3 |
Classes with closest relation at Level 1 |